Krystal Biotech Inc (KRYS)
182.29
+4.19
(+2.35%)
USD |
NASDAQ |
Nov 21, 16:00
182.47
+0.18
(+0.10%)
After-Hours: 20:00
Krystal Biotech Profit Margin (Quarterly): 32.42% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 32.42% |
| June 30, 2024 | 22.15% |
| Date | Value |
|---|---|
| March 31, 2024 | 2.06% |
| December 31, 2023 | 20.62% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
2.06%
Minimum
Mar 2024
32.42%
Maximum
Sep 2024
19.31%
Average
21.39%
Median
Profit Margin (Quarterly) Benchmarks
| Bioventus Inc | -3.47% |
| ADMA Biologics Inc | 29.96% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Amicus Therapeutics Inc | -4.75% |
| Rhythm Pharmaceuticals Inc | -131.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 6.45% |
| Return on Assets | 6.00% |
| Return on Invested Capital | 6.45% |
| Gross Profit Margin (Quarterly) | 92.03% |
| Operating Margin (Quarterly) | 41.67% |
| Return on Net Operating Assets | 22.05% |